Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.
Hoellein A, Fallahi M, Schoeffmann S, Steidle S, Schaub FX, Rudelius M, Laitinen I, Nilsson L, Goga A, Peschel C, Nilsson JA, Cleveland JL, Keller U.
Hoellein A, et al. Among authors: schoeffmann s.
Blood. 2014 Sep 25;124(13):2081-90. doi: 10.1182/blood-2014-06-584524. Epub 2014 Aug 20.
Blood. 2014.
PMID: 25143484
Free PMC article.